ACCUTEST RESEARCH LABORATORIES
Ex-Blackstone India co-head Mathew Cyriac’s fund buys 80% stake in Accutest Research LaboratoriesIn the next five years, drug patents with sales worth $170 billion will expire globally, driving demand for cost-effective generic drugs. A...
- Load More